Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT06217302

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06217302
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06217302. Randomized; quadruple masking; primary purpose prevention. Start 2024-10-31 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Acronym
SUGARNSALT
Condition
Diabetic Nephropathies
Condition
Kidney Failure, Chronic
Condition
Diabetes Mellitus Type 1
Condition
Heart Failure
Intervention (Drug)
Sotagliflozin
Intervention (Drug)
Placebo
Lead sponsor
Alessandro Doria (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)
Collaborator
The Kidney Foundation of Canada (class: other)
Collaborator
The Cleveland Clinic (class: other)
Collaborator
University of Michigan (class: other)
Collaborator
University of Colorado, Denver (class: other)
Collaborator
Northwestern University (class: other)
Collaborator
Washington University School of Medicine (class: other)
Collaborator
State University of New York - Upstate Medical University (class: other)
Collaborator
Providence Medical Research Center (class: other)
Collaborator
Stanford University (class: other)
Collaborator
Montefiore Medical Center (class: other)
Collaborator
University of Toronto (class: other)
Collaborator
University Health Network, Toronto (class: other)
Collaborator
University of Calgary (class: other)
Collaborator
University of Alberta (class: other)
Collaborator
University of British Columbia (class: other)
Collaborator
Institut de Recherches Cliniques de Montreal (class: other)
Collaborator
LMC Diabetes & Endocrinology Ltd. (class: other)
Collaborator
Joslin Diabetes Center (class: other)
Collaborator
Lexicon Pharmaceuticals (class: industry)
Collaborator
DexCom, Inc. (class: industry)
Collaborator
University of Washington (class: other)
Collaborator
Breakthrough T1D (class: other)
Collaborator
AdventHealth (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 17

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 48 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 15 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.

    Organization00f54p054

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 21 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 11 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 25 trials in this atlas.

    Organization0160cpw27

Record details

Record id
cardio:ct-nct06217302
Content hash
8aa41d65bada7a4e4635bc53c6dac9dd2be04793026b22d5d8af7ccd8a9ba23b